S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CVKD Cadrenal Therapeutics Inc

19.34

-0.45 (-2.27%)

Jan 24 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Cadrenal Therapeutics (NASDAQ:CVKD)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Cadrenal Therapeutics Charts.

Cadrenal Therapeutics (NASDAQ:CVKD)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Cadrenal Therapeutics Charts.

Cadrenal Therapeutics Inc News

Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Thursday 9 January 2025 (2 weeks ago) • Business Wire

Cadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular Indications
Tuesday 31 December 2024 (4 weeks ago) • Business Wire

Form S-8 - Securities to be offered to employees in employee benefit plans
Monday 23 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 20 December 2024 (1 month ago) • Edgar (US Regulatory)

Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings
Wednesday 18 December 2024 (1 month ago) • Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]
Monday 25 November 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Sunday 24 November 2024 (2 months ago) • Edgar (US Regulatory)

Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
Tuesday 19 November 2024 (2 months ago) • PR Newswire (US)

Form S-3 - Registration statement under Securities Act of 1933
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Tuesday 12 November 2024 (2 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

More Cadrenal Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions